Different Clinical Presentations and Outcomes of Disseminated Varicella in Children With Primary and Acquired Immunodeficiencies.
disseminated varicella
innate immunity
primary immumunodeficiencies
steroids
varicella
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
08
2020
accepted:
09
10
2020
entrez:
30
11
2020
pubmed:
1
12
2020
medline:
10
7
2021
Statut:
epublish
Résumé
Primary infection with varicella-zoster virus (VZV) causes chickenpox, a benign and self-limited disease in healthy children. In patients with primary or acquired immunodeficiencies, primary infection can be life-threatening, due to rapid dissemination of the virus to various organs [lung, gastrointestinal tract, liver, eye, central nervous system (CNS)]. We retrospectively described and compared the clinical presentations and outcomes of disseminated varicella infection (DV) in patients with acquired (AID) (
Identifiants
pubmed: 33250898
doi: 10.3389/fimmu.2020.595478
pmc: PMC7674974
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Case Reports
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
595478Informations de copyright
Copyright © 2020 Bastard, Galerne, Lefevre-Utile, Briand, Baruchel, Durand, Landman-Parker, Gouache, Boddaert, Moshous, Gaudelus, Cohen, Deschenes, Fischer, Blanche, de Pontual and Neven.
Références
Lancet. 2006 Oct 14;368(9544):1365-76
pubmed: 17046469
Pediatrics. 1975 Sep;56(3):388-97
pubmed: 1088828
BMC Infect Dis. 2016 Jun 07;16:254
pubmed: 27266273
J Clin Immunol. 2018 Jan;38(1):10-12
pubmed: 29204803
J Allergy Clin Immunol. 2015 Aug;136(2):402-12
pubmed: 25724123
J Clin Immunol. 2019 Apr;39(3):298-308
pubmed: 30838481
Oncol Lett. 2016 Aug;12(2):809-814
pubmed: 27446355
Am J Dis Child. 1983 Sep;137(9):883-5
pubmed: 6613954
Vaccine. 2015 May 15;33(21):2406-13
pubmed: 25839105
Clin Exp Immunol. 2014 Dec;178(3):459-69
pubmed: 25046553
Lancet. 2006 Dec 23;368(9554):2208
pubmed: 17189028
Pediatrics. 1993 Aug;92(2):223-8
pubmed: 8337020
J Clin Invest. 2012 Mar;122(3):814-20
pubmed: 22354170
J Clin Immunol. 2015 Nov;35(8):754-60
pubmed: 26515615
Nat Rev Immunol. 2017 Apr;17(4):233-247
pubmed: 28192415
J Infect Chemother. 2016 Dec;22(12):822-825
pubmed: 27496601
Immunol Rev. 2019 Jan;287(1):241-252
pubmed: 30565242
Drugs. 1999 Feb;57(2):187-206
pubmed: 10188760
Orphanet J Rare Dis. 2018 May 31;13(1):85
pubmed: 29855327
Pediatrics. 2005 Oct;116(4):e525-9
pubmed: 16199681
Ann Intern Med. 1988 Feb;108(2):221-37
pubmed: 2829675
N Engl J Med. 2015 Jun 18;372(25):2409-22
pubmed: 26083206
J Biomed Inform. 2018 Apr;80:52-63
pubmed: 29501921
Immunol Cell Biol. 2019 Apr;97(4):389-402
pubmed: 30779216
J Clin Invest. 2017 May 1;127(5):1991-2006
pubmed: 28414293
Case Rep Pediatr. 2017;2017:6708046
pubmed: 28900551
J Clin Immunol. 2020 Jan;40(1):66-81
pubmed: 32048120
Blood Res. 2016 Dec;51(4):249-255
pubmed: 28090487
Pediatr Blood Cancer. 2012 Jan;58(1):12-6
pubmed: 20848637
Curr Opin Immunol. 2020 Feb;62:106-122
pubmed: 32014647
Cancer Treat Res. 2014;161:371-411
pubmed: 24706232
Cancer Treat Res. 2014;161:319-49
pubmed: 24706230
Lancet. 1983 Oct 8;2(8354):814-6
pubmed: 6137648
J Clin Invest. 2017 Sep 1;127(9):3543-3556
pubmed: 28783042
J Infect Dis. 1998 Nov;178 Suppl 1:S43-7
pubmed: 9852972
J Clin Invest. 2012 Mar;122(3):821-32
pubmed: 22354167
BMC Pediatr. 2011 May 10;11:31
pubmed: 21569228